Case Analysis on GLP-1 Preparation Used in 3 T2DM Patients with Hepatic Insufficiency and Obesity
- VernacularTitle:3例肝功能不良合并肥胖T2DM患者使用GLP-1制剂的病例分析
- Author:
Fen JIN
1
,
2
;
Qi HU
;
Juan ZHENG
;
Xueyu ZHONG
;
Yanxiang CHEN
Author Information
1. 武汉市第七医院药剂科 武汉430071
2. 华中科技大学同济医学院附属协和医院
- Keywords:
Hepatic insufficiency;
Obesity;
Type 2 diabetes;
GLP-1
- From:
China Pharmacist
2018;21(10):1823-1826
- CountryChina
- Language:Chinese
-
Abstract:
Clinical pharmacists actively participated in the glucose-lowering therapy for three type 2 diabetes patients with obesity and hepatic insufficiency to explore the role of clinical pharmacists in clinical treatment. Through the participation in the formulation of drug treatment by clinical pharmacists, GLP-1 preparation was used for hypoglycemic treatment, and the effect was promising. There was no significant change in the patients' liver function. By actively participating in the formulation of glucose-lowering therapy, clini-cal pharmacists can improve the effectiveness and safety of drug treatment.
